Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology

Modern Pathology

Volumn 19, Issue 12, 2006, Pages 1536-1545

  Orazi, Attilio ^a   Chiu, Ronald ^a   O'Malley, Dennis P ^a   Czader, Magdalena ^a   Allen, Susan L ^a   An, Caroline ^a   Vance, Gail H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute transformation; Atypical chronic myeloid leukemia; Chronic myelogenous leukemia; Chronic myelomonocytic leukemia; Immunohistochemistry; Plasmacytoid monocyte

Indexed keywords

CD123 ANTIGEN; CD163 ANTIGEN; CD34 ANTIGEN; CD68 ANTIGEN; CELL MARKER; GLYCOPROTEIN IB ALPHA; PARAFFIN; PROTEIN CD68R; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; ASPIRATION; ASPIRATION BIOPSY; ATYPICAL CHRONIC MYELOID LEUKEMIA; BLAST CELL; BLOOD; BONE MARROW BIOPSY; CELL SIZE; CELL STRUCTURE; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA TYPE I; CHRONIC MYELOMONOCYTIC LEUKEMIA TYPE II; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MACROPHAGE; MALE; MEGAKARYOCYTE; MONOCYTE; PLASMACYTOID MONOCYTE; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BIOPSY, NEEDLE; BONE MARROW; BONE MARROW CELLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MEGAKARYOCYTES; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 33751206504     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800707     Document Type: Article

References (38)

1. Vardiman JW, Imbert M, Pierre R, et al. Chronic myelomonocytic leukemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon IARC Press: Lyon, France, 2001, pp 49-52.
2. Bennett JM, Catovsky D, Daniel MT, et al. The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukemia. Proposals by the French-American-British cooperative leukemia group. Br J Haematol 1994;87:746-754.
3. Fenaux P, Beuscart R, Lai JL, et al. Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases. J Clin Oncol 1988;6:1417-1424.
4. Germing U, Gattermann N, Minning H, et al. Problems in the classification of CMML-dysplastic versus proliferative type. Leuk Res 1998;22:871-878.
5. Storniolo AM, Moloney WC, Rosenthal DS, et al. Chronic myelomonocytic leukemia. Leukemia 1990;4:766-770.
6. Tefferi A, Hoagland HC, Therneau TM, et al. Chronic myelomonocytic leukemia: natural history and prognostic determinants. Mayo Clin Proc 1989;64:1246-1254.
7. Orazi A, O'Malley DP, Jiang J, et al. Acute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemia. Mod Pathol 2005;18:603-614.
8. Martiat P, Michaux JL, Rodhain J. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. Blood 1991;78:205-211.
9. Oscier DG. Atypical chronic myeloid leukemia, a distinct clinical entity related to the myelodysplastic syndrome? Br J Haematol 1996;92:582-586.
10. Manoharan A, Horsley R, Pitney WR. The reticulin content of bone marrow in acute leukaemia in adults. Br J Haematol 1979;43:185-190.
11. Orazi A. CD34 immunoperoxidase staining for the diagnosis of myelodysplastic syndromes and chronic myeloid leukaemia. J Clin Pathol 1995;48:884 (Letter).
12. Kurec AS, Cruz VE, Barrett D, et al. Immunophenotyping of acute leukemias using paraffin-embedded tissue sections. Am J Clin Pathol 1990;93:502-509.
13. Manaloor EJ, Neiman RS, Heilman DK, et al. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry. Am J Clin Pathol 2000;113:814-822.
14. Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol 2004;122:794-801.
15. Nguyen TT, Schwartz EJ, West RB, et al. Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am J Surg Pathol 2005;29:617-624.
16. Chen YC, Chou JM, Ketterling RP, et al. Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia. Am J Clin Pathol 2003;120:874-881.
17. Vermi W, Facchetti F, Rosati S, et al. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol 2004;28:585-595.
18. Palmer CG, Blouin JL, Bull MJ, et al. Cytogenetics and molecular analysis of a ring (21) in a patient with partial trisomy 21 and megakaryocytic leukemia. Am J Med Genet 1995;57:527-536.
19. Orazi A, Neiman RS, Cualing H, et al. CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia. Am J Clin Pathol 1994;101:426-468.
20. Tefferi A. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronicmyelogenous leukemia. Semin Hematol 1999;36:3-8 (Review).
21. Bacher U, Haferlach T, Kern W, et al. Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information. Ann Hematol 2005;84:250-257.
22. Golub TR, Barker GF, Lovett M, et al. Fusion of PDGF receptor to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994;77:307-316.
23. Steer EJ, Cross NC. Myeloproliferative disorders with translocations of chromosome 5q31-35; role of the platelet-derived growth factor receptor Beta. Acta Haematol 2002;107:113-122.
24. van der Plas DC, Grosveld G, Hagemeijer A. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML. Cancer Genet Cytogenet 1991;52:143-156 (Review).
25. Plata E, Viniou N, Abazis D, et al. Cytogenetic analysis and RAS mutations in primary myelodysplastic syndromes. Cancer Genet Cytogenet 1999;111:124-129.
26. Paquette RL, Landaw EM, Pierre RV, et al. N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome. Blood 1993;82:590-599.
27. Johan MF, Goodeve AC, Bowen DT, et al. JAK2 V617F Mutation is uncommon in chronic myelomonocytic leukaemia. Br J Haematol 2005;130:968 (Letter).
28. Galton DA. Haematological differences between chronic granulocytic leukaemia, atypical chronic myeloid leukaemia, and chronic myelomonocytic leukaemia. Leuk Lymphoma 1992;7:343-350 (Review).
29. Misialek MJ, Pechet L. A diagnostic dilemma: chronic myelomonocytic leukemia versus atypical chronic myeloid leukemia. A case report and review of the literature. Acta Haematol 1997;98:221-227.
30. Saito N, Pulford KA, Breton-Gorius J, et al. Ultrastructural localization of the CD68 macrophage-associated antigen in human blood neutrophils and monocytes. Am J Pathol 1991;139:1053-1059.
31. Feuk-Lagerstedt E, Samuelsson M, Mosgoeller W, et al. The presence of stomatin in detergent-insoluble domains of neutrophil granule membranes. J Leukoc Biol 2002;72:970-977.
32. Davey FR, Erber WN, Gatter KC, et al. Abnormal neutrophils in acute myeloid leukemia and myelodysplastic syndrome. Hum Pathol 1988;19:454-459.
33. Moretti S, Lanza F, Spisani S, et al. Neutrophils from patients with myelodysplastic syndromes: relationship between impairment of granular contents, complement receptors, functional activities and disease status. Leukemia Lymphoma 1994;13:471-477.
34. Miescher PA, Farquet JJ. Chronic myelomonocytic leukemia in adults. Semin Hematol 1974;11:129-139.
35. Ramshaw HS, Bardy PG, Lee MA, et al. Chronic myelomonocytic leukemia requires granulocytemacrophage colony-stimulating factor for growth in vitro and in vivo. Exp Hematol 2002;30:1124-1131.
36. Geissler K, Ohler L, Fodinger M, et al. Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells. J Exp Med 1996;184:1377-1384.
37. Soligo D, Delia D, Oriani A, et al. Identification of CD34+cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody. Leukemia 1991;12:1026-1030.
38. Orazi A, Cattoretti G, Soligo D, et al. Therapy related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment. Leukemia 1993;7:838-847.